Citations (46)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (4)
Susan
S. Schiffman & Kristina
I. Rother. (2013) Sucralose, A Synthetic Organochlorine Sweetener: Overview Of Biological Issues. Journal of Toxicology and Environmental Health, Part B 16:7, pages 399-451.
Read now
Read now
M. D. Lee, E. Ayanoglu & L. Gong. (2006) Drug-induced changes in P450 enzyme expression at the gene expression level: A new dimension to the analysis of drug–drug interactions. Xenobiotica 36:10-11, pages 1013-1080.
Read now
Read now
T. SHIRAGA, H. KANEKO, K. IWASAKI, Z. TOZUKA, A. SUZUKI & T. HATA. (1999) Identification of cytochrome P450 enzymes involved in the metabolism of zotepine, an antipsychotic drug, in human liver microsomes. Xenobiotica 29:3, pages 217-229.
Read now
Read now
D. F. V. LEWIS, B. G. LAKE, M. DICKINS, P. J. EDDERSHAW, M. H. TARBIT & P. S. GOLDFARB. (1999) Molecular modelling of CYP2B6, the human CYP2B isoform, by homology with the substrate-bound CYP102 crystal structure: evaluation of CYP2B6 substrate characteristics, the cytochrome b5 binding site and comparisons with CYP2B1 and CYP2B4. Xenobiotica 29:4, pages 361-393.
Read now
Read now
Articles from other publishers (42)
Yoshiya Yamamura, Kouichi Yoshinari & Yasushi Yamazoe. (2023) Construction of a fused grid-based CYP2C19-Template system and the application. Drug Metabolism and Pharmacokinetics 48, pages 100481.
Crossref
Crossref
Yaxin Xiong, Qingyang Shi, Nathan D. Sy, Nicole M. Dennis, Daniel Schlenk & Jay Gan. (2022) Influence of methylation and demethylation on plant uptake of emerging contaminants. Environment International 170, pages 107612.
Crossref
Crossref
Neil Sandson. (2022) Important Drug-Drug Interactions for the Addiction Psychiatrist. Psychiatric Clinics of North America 45:3, pages 431-450.
Crossref
Crossref
Rohit Pal, Karanvir Singh, Shah Alam Khan, Pooja Chawla, Bhupinder Kumar & Md Jawaid Akhtar. (2021) Reactive metabolites of the anticonvulsant drugs and approaches to minimize the adverse drug reaction. European Journal of Medicinal Chemistry 226, pages 113890.
Crossref
Crossref
Sundus Khalid, Muhammad Fawad Rasool, Imran Imran, Abdul Majeed, Hamid Saeed, Anees ur Rehman, Waseem Ashraf, Tanveer Ahmad, Yousef A. Bin Jardan & Faleh Alqahtani. (2021) A Physiologically Based Pharmacokinetic Model for Predicting Diazepam Pharmacokinetics after Intravenous, Oral, Intranasal, and Rectal Applications. Pharmaceutics 13:9, pages 1480.
Crossref
Crossref
Rakshit S. Tanna, Dan-Dan Tian, Nadja B. Cech, Nicholas H. Oberlies, Allan E. Rettie, Kenneth E. Thummel & Mary F. Paine. (2021) Refined Prediction of Pharmacokinetic Kratom-Drug Interactions: Time-Dependent Inhibition Considerations. Journal of Pharmacology and Experimental Therapeutics 376:1, pages 64-73.
Crossref
Crossref
Habibur Rahman, S.K. Manirul Haque & Masoom Raza Siddiqui. (2020) A Comprehensive Review on Importance and Quantitation of Atypical Antipsychotic Drugs and their Active Metabolites in Commercial Dosage Forms. Current Pharmaceutical Analysis 16:8, pages 989-1019.
Crossref
Crossref
Yildiz Yilmaz, Gareth Williams, Markus Walles, Nenad Manevski, Stephan Krähenbühl & Gian Camenisch. (2019) Comparison of Rat and Human Pulmonary Metabolism Using Precision-cut Lung Slices (PCLS). Drug Metabolism Letters 13:1, pages 53-63.
Crossref
Crossref
Yasushi Yamazoe, Takahiro Goto & Masahiro Tohkin. (2019) Reconstitution of CYP3A4 active site through assembly of ligand interactions as a grid-template: Solving the modes of the metabolism and inhibition. Drug Metabolism and Pharmacokinetics 34:2, pages 113-125.
Crossref
Crossref
André Dallmann, Ibrahim Ince, Katrin Coboeken, Thomas Eissing & Georg Hempel. (2017) A Physiologically Based Pharmacokinetic Model for Pregnant Women to Predict the Pharmacokinetics of Drugs Metabolized Via Several Enzymatic Pathways. Clinical Pharmacokinetics 57:6, pages 749-768.
Crossref
Crossref
Jarrett R. Amsden & Paul O. Gubbins. 2018. Drug Interactions in Infectious Diseases: Antimicrobial Drug Interactions. Drug Interactions in Infectious Diseases: Antimicrobial Drug Interactions
425
501
.
William D. Hedrich, Hazem E. Hassan & Hongbing Wang. (2016) Insights into CYP2B6-mediated drug–drug interactions. Acta Pharmaceutica Sinica B 6:5, pages 413-425.
Crossref
Crossref
TIANBO JIN, XIYANG ZHANG, TINGTING GENG, XUGANG SHI, LI WANG, DONGYA YUAN & LONGLI KANG. (2016) Genotype-phenotype analysis of CYP2C19 in the Tibetan population and its potential clinical implications in drug therapy. Molecular Medicine Reports 13:3, pages 2117-2123.
Crossref
Crossref
Jose Valdes, Douglas L. Boggs, Angela A. Boggs & Jose A. Rey. 2016. Applied Clinical Pharmacokinetics and Pharmacodynamics of Psychopharmacological Agents. Applied Clinical Pharmacokinetics and Pharmacodynamics of Psychopharmacological Agents
471
495
.
M. Ya. Golovenko & V. B. Larionov. (2014) Kinetics of hydrolysis of 1,4-benzodiazepine derivative by carboxylesterases in mice organism. The Ukrainian Biochemical Journal 86:4, pages 150-157.
Crossref
Crossref
Nicholas E. Calcaterra & James C. Barrow. (2014) Classics in Chemical Neuroscience: Diazepam (Valium). ACS Chemical Neuroscience 5:4, pages 253-260.
Crossref
Crossref
David E. Moody. 2012. Handbook of Drug Interactions. Handbook of Drug Interactions
25
116
.
Simona Salerno, Carla Campana, Sabrina Morelli, Enrico Drioli & Loredana De Bartolo. (2011) Human hepatocytes and endothelial cells in organotypic membrane systems. Biomaterials 32:34, pages 8848-8859.
Crossref
Crossref
Shu-Feng Zhou, Zhi-Wei Zhou & Min Huang. (2010) Polymorphisms of human cytochrome P450 2C9 and the functional relevance. Toxicology 278:2, pages 165-188.
Crossref
Crossref
Shayne Cox GadEugene G. Hrycay & Stelvio M. Bandiera. 2010. Pharmaceutical Sciences Encyclopedia. Pharmaceutical Sciences Encyclopedia.
Ramesh B. Bambal & Stephen E. Clarke. 2009. Evaluation of Drug Candidates for Preclinical Development. Evaluation of Drug Candidates for Preclinical Development
55
107
.
Katsuhiko Mizuno, Miki Katoh, Hirotoshi Okumura, Nao Nakagawa, Toru Negishi, Takanori Hashizume, Miki Nakajima & Tsuyoshi Yokoi. (2009) Metabolic Activation of Benzodiazepines by CYP3A4. Drug Metabolism and Disposition 37:2, pages 345-351.
Crossref
Crossref
Kazunobu Aoyama, Kouichi Yoshinari, Hye-Ji Kim, Kiyoshi Nagata & Yasushi Yamazoe. (2009) Simultaneous Expression of Plural Forms of Human Cytochrome P450 at Desired Ratios in HepG2 Cells: Adenovirus-mediated Tool for Cytochrome P450 Reconstitution. Drug Metabolism and Pharmacokinetics 24:3, pages 209-217.
Crossref
Crossref
Ali Acikgöz, Najibulla Karim, Shibashish Giri, Wolfgang Schmidt-Heck & Augustinus Bader. (2009) Two compartment model of diazepam biotransformation in an organotypical culture of primary human hepatocytes. Toxicology and Applied Pharmacology 234:2, pages 179-191.
Crossref
Crossref
Jessica R. Oesterheld, Kelly Cozza & Neil B. Sandson. (2008) Oral Contraceptives. Psychosomatics 49:2, pages 168-175.
Crossref
Crossref
Einosuke Tanaka, Takako Nakamura, Shinichi Inomata & Katsuya Honda. (2006) Effects of Premedication Medicines on the Formation of the CYP3A4-Dependent Metabolite of Ropivacaine, 2', 6'-Pipecoloxylidide, on Human Liver Microsomes in vitro. Basic <html_ent glyph="@amp;" ascii="&"/> Clinical Pharmacology <html_ent glyph="@amp;" ascii="&"/> Toxicology 98:2, pages 181-183.
Crossref
Crossref
A. Nagashima, E. Tanaka, S. Inomata, K. Honda & S. Misawa. (2005) A study of the in vitro interaction between lidocaine and premedications using human liver microsomes*. Journal of Clinical Pharmacy and Therapeutics 30:2, pages 185-188.
Crossref
Crossref
Kenichi NAKAZONO, Yoshiyuki WATANABE, Shinichi NAKAYA, Yoshie ASAMI, Keisou MASUHARA, Fumio ITOH & Hiroyasu OGATA. (2005) Impairment State of Cognitive Performance and the Affecting Factors in Outpatients Following Gastrointestinal Endoscopy after Single-dose Diazepam. YAKUGAKU ZASSHI 125:3, pages 307-314.
Crossref
Crossref
Stanislav Micuda, Lucie Mundlova, Eva Anzenbacherova, Pavel Anzenbacher, Jaroslav Chladek, Leos Fuksa & Jirina Martinkova. (2004) Inhibitory effects of memantine on human cytochrome P450 activities: prediction of in vivo drug interactions. European Journal of Clinical Pharmacology 60:8, pages 583-589.
Crossref
Crossref
Masahiro Hiratsuka, Yudai Hinai, Yumiko Konno, Hisayoshi Nozawa, Shoetsu Konno & Michinao Mizugaki. (2004) Three Novel Single Nucleotide Polymorphisms (SNPs) of the CYP2B6 Gene in Japanese Individuals. Drug Metabolism and Pharmacokinetics 19:2, pages 155-158.
Crossref
Crossref
David E. Moody. 2004. Handbook of Drug Interactions. Handbook of Drug Interactions
3
88
.
Franck Clarot, Jean Pierre Goullé, E Vaz & Bernard Proust. (2003) Tramadol–benzodiazepines and buprenorphine–benzodiazepines: two potentially fatal cocktails?. Journal of Clinical Forensic Medicine 10:2, pages 125-126.
Crossref
Crossref
Hideto Jinno, Toshiko Tanaka-Kagawa, Akiko Ohno, Yuko Makino, Erika Matsushima, Nobumitsu Hanioka & Masanori Ando. (2003) Functional Characterization of Cytochrome P450 2B6 Allelic Variants. Drug Metabolism and Disposition 31:4, pages 398-403.
Crossref
Crossref
Leah M Hesse, Lisa L von Moltke & David J Greenblatt. (2003) Clinically Important Drug Interactions with Zopiclone, Zolpidem and Zaleplon. CNS Drugs 17:7, pages 513-532.
Crossref
Crossref
A Nagashima, E TanakaS Inomata & S Misawa. (2016) A study of the in vitro clinical interaction between lidocaine and premedications using rat liver microsomes. Human & Experimental Toxicology 21:8, pages 453-456.
Crossref
Crossref
Qinmi Wang & James R. Halpert. (2002) Combined Three-Dimensional Quantitative Structure-Activity Relationship Analysis of Cytochrome P450 2B6 Substrates and Protein Homology Modeling. Drug Metabolism and Disposition 30:1, pages 86-95.
Crossref
Crossref
Karthik Venkatakrishnan, Lisa L. von Moltke & David J. Greenblatt. (2013) Human Drug Metabolism and the Cytochromes P450: Application and Relevance of In Vitro Models. The Journal of Clinical Pharmacology 41:11, pages 1149-1179.
Crossref
Crossref
Magang Shou, Tin Lu, Kristopher W. Krausz, Yang Sai, Tianjian Yang, Kenneth R. Korzekwa, Frank J. Gonzalez & Harry V. Gelboin. (2000) Use of inhibitory monoclonal antibodies to assess the contribution of cytochromes P450 to human drug metabolism. European Journal of Pharmacology 394:2-3, pages 199-209.
Crossref
Crossref
P.E.B Reilly, S.R Mason & M.A Read. (1999) Human, rat and crocodile liver microsomal monooxygenase activities measured using diazepam and nifedipine: effects of CYP3A inhibitors and relationship to immunochemically detected CYP3A apoprotein. Comparative Biochemistry and Physiology Part C: Pharmacology, Toxicology and Endocrinology 122:2, pages 197-204.
Crossref
Crossref
Karthik Venkatakrishnan, Lisa L. von Moltke & David J. Greenblatt. (1998) Relative Quantities of Catalytically Active CYP 2C9 and 2C19 in Human Liver Microsomes: Application of the Relative Activity Factor Approach. Journal of Pharmaceutical Sciences 87:7, pages 845-853.
Crossref
Crossref
JEFFREY A. KLEIN & NORMA KASSARJDIAN. (1997) Lidocaine Toxicity with Tumescent Liposuction. Dermatologic Surgery 23:12, pages 1169-1174.
Crossref
Crossref
Yaxin Xiong, Qingyang Shi, Nathan D. Sy, Nicole M. Dennis, Daniel Schlenk & Jay Gan. (2022) Influence of Methylation and Demethylation on Plant Uptake of Emerging Contaminants. SSRN Electronic Journal.
Crossref
Crossref